2017
DOI: 10.1016/j.envpol.2017.07.057
|View full text |Cite
|
Sign up to set email alerts
|

Altered vulnerability to asthma at various levels of ambient Benzo[a]Pyrene by CTLA4, STAT4 and CYP2E1 polymorphisms

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
20
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
5
1

Relationship

1
5

Authors

Journals

citations
Cited by 26 publications
(21 citation statements)
references
References 53 publications
1
20
0
Order By: Relevance
“…In our investigation, we could not directly examine whether non-atopic asthma represents T-helper 2 or type 2 low asthma, while atopic asthma captures Thelper 2 or type 2 high asthma, two known endotypes [3,30]. This is because we did not measure typical [9,10,13,19,[31][32][33][34][35][36]. Both the laboratory and epidemiologic evidence have shown that PAHs could induce or enhance allergic sensitization, exacerbate pre-existing asthma, and enhance the risk of de novo asthma development [33,37,38].…”
Section: Discussionmentioning
confidence: 96%
See 4 more Smart Citations
“…In our investigation, we could not directly examine whether non-atopic asthma represents T-helper 2 or type 2 low asthma, while atopic asthma captures Thelper 2 or type 2 high asthma, two known endotypes [3,30]. This is because we did not measure typical [9,10,13,19,[31][32][33][34][35][36]. Both the laboratory and epidemiologic evidence have shown that PAHs could induce or enhance allergic sensitization, exacerbate pre-existing asthma, and enhance the risk of de novo asthma development [33,37,38].…”
Section: Discussionmentioning
confidence: 96%
“…For example, the interquartile range of ambient B[a]P levels during our exposure window of interest (i.e. November, 2008) is representative of the ambient concentrations from the earlier years [12].…”
Section: Discussionmentioning
confidence: 99%
See 3 more Smart Citations